Graham H. Bevan

Learn More
BACKGROUND Extracellular microRNAs (miRNAs) embedded in circulating exosomes may serves as prognostic biomarkers in cancer. OBJECTIVE To identify and evaluate plasma exosomal miRNAs for prognosis in castration-resistant prostate cancer (CRPC). DESIGN, SETTING, AND PARTICIPANTS RNA sequencing was performed to identify candidate exosomal miRNAs associated(More)
75 Background: We investigated the association of germline variation in ten candidate genes important in prostate cancer biology (NKX3-1, JAK2, SLCO2B1, STAT3, CYP19A1, HSD17B4, TRMT11, PRMT3, HSD17B12, NCOA4) with overall survival (OS) in a cohort of metastatic CRPC stage patients. METHODS Patients (N=497) were enrolled at the time of androgen(More)
BACKGROUND Prostate cancer (PCa) is a leading cause of cancer death of men worldwide. In hormone-sensitive prostate cancer (HSPC), androgen deprivation therapy (ADT) is widely used, but an eventual failure on ADT heralds the passage to the castration-resistant prostate cancer (CRPC) stage. Because predicting time to failure on ADT would allow improved(More)
This study tested the potential of circulating RNA-based signals as predictive biomarkers for docetaxel response in patients with metastatic castration-resistant prostate cancer (CRPC). RNA was analyzed in blood from six CRPC patients by whole-transcriptome sequencing (total RNA-sequencing) before and after docetaxel treatment using the Illumina's HiSeq(More)
In this study, we used a in-silico cardiac wedge model with high spatial resolution to evaluate the role of transmural heterogeneity on T-wave morphology. Computer simulations were performed with transmural electrograms recorded with a pacing rate of 60 bpm. QT and TpTe intervals were extracted. The model consisted of i) a human left-ventricular wedge mesh(More)
  • 1